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Estrogen is of importance for the regulation of hair
growth and epidermal thickness. The effects of estro-
gen have predominantly been studied in females;
however, recent studies demonstrate that estrogen
also is critical for males. The aim of this study was
to investigate the relative functional importance of
estrogen receptor a and estrogen receptor b in the
regulation of the hair follicle cycling and epidermal
thickness in male mice. Seven month old transgenic
male mice, lacking estrogen receptor a (ERKO),
estrogen receptor b (BERKO), or both receptors
(DERKO), were orchidectomized and treated for
3 week with 17b-estradiol or vehicle. Orchidectomy
induced a synchronized anagen phase of the hair fol-
licles, which was inhibited by 17b-estradiol treatment
in wild-type and BERKO mice, but not in ERKO
and DERKO mice. Furthermore, 17b-estradiol treat-
ment increased the thickness of epidermis in wild-
type and BERKO mice, but not in ERKO and
DERKO. This study demonstrates that estrogen is of
importance for the regulation of hair follicle cycling
and epidermal thickness in male mice. The effect on
hair follicle cycling is caused by an estrogen receptor
a mediated inhibition of telogen±anagen transition
and the effect of estrogen to increase epidermal
thickness is associated with an estrogen receptor a
mediated increase in the proliferative rate of the
keratinocytes in the basal cell layer of the epidermis.
Key words: estrogen receptors/epidermal thickness/hair
follicle cycling/transgenic. J Invest Dermatol 119:1053±
1058, 2002
H
air growth is affected by several factors, including
growth and transcription factors, cytokines, and
hormones (Stenn and Paus, 2001). A hair follicle
consists of epithelial components, which include the
inner and outer root sheath and the hair shaft, and
mesenchymal components, which include the dermal papilla and
connective tissue sheath. Normal development of hair follicles
depends on the interactions of the follicular epithelium with the
adjacent mesenchymal dermal papilla (Hardy, 1992). After
morphogenesis, the dermal papilla and the upper portion of the
follicle remain throughout the hair cycle, whereas the lower follicle
undergoes a cyclic pattern of three stages: growing (anagen),
structural regression (catagen), and resting (telogen) (Dry, 1926;
Hardy, 1992; Stenn and Paus, 2001). During the anagen phase, the
follicle moves from the dermis down to the subcutis (Stenn and
Paus, 2001). The interaction between cells of the dermal papilla and
those of the matrix is considered to play an important part in this
cycle; however, the actual signals that initiate and terminate the
cycle of hair growth remain poorly understood.
Earlier studies, using radiolabeled estradiol followed by auto-
radiography, suggest that both the epidermis and the dermal papilla
are estrogen target tissues (Stumpf et al, 1974; Bidmon et al, 1990).
Several studies have established the in¯uence of estrogen on the
rodent hair cycle (Jackson and Ebling, 1972; Hale and Ebling,
1975, 1979). 17b-estradiol inhibits, whereas the estrogen antagonist
ICI 182780 stimulates hair growth in gonadectomized male as well
as female rodents (Jackson and Ebling, 1972; Hale and Ebling,
1975, 1979; Smart et al, 1999). This effect of estrogen on hair
growth is due to an inhibition of the telogen±anagen transition (Oh
and Smart, 1996; Chanda et al 2000). Similarly, gonadectomy
results in a profound and rapid telogen to anagen transition
(Chanda et al 2000). An effect of estrogen on hair growth also in
humans is supported by the fact that pregnant women demonstrate
a slower rate of replacement of spontaneous hair loss or plucked
hair, presumably due to high levels of circulating estrogen
(Montagna and Parakkal, 1974). Topical treatment of mouse skin
with 17b-estradiol arrest follicles in telogen at the site of
application, indicating that an estrogen receptor (ER) pathway
within the dermal papilla regulates telogen±anagen transition of the
hair follicle (Oh and Smart, 1996).
Androgens are aromatized to estrogen locally in the hair follicle
(Schweikert et al, 1975). Estrogen acts via ER and there are two
known ER, denoted a (ERa) and b (ERb). ERa is expressed in
the skin of both humans and rodents, whereas con¯icting results
have been presented regarding the expression of ERb in the skin
(Stumpf et al, 1974; Uzuka et al, 1978; Hasselquist et al, 1980;
Punnonen et al, 1980; Bidmon et al, 1990; Oh and Smart, 1996;
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Brandenberger et al, 1997; Chanda et al 2000). The functional role
of ERa and ERb in the regulation of hair growth is unknown.
The epidermis is a strati®ed squamous epithelium composed
primarily of keratinocytes that resides at the surface of the skin. Its
proliferative compartment is located in the innermost basal layer,
where stem cells are attached to an underlying basement mem-
brane. The tissue is dynamic and self-renewing, and basal cells
periodically lose their contact with the basement membrane and
activate a program of terminal differentiation (Fuchs, 1993). As the
cells move toward the surface, they progress through three distinct
stages: spinous, granular, and stratum corneum. Cells in the
different stages express keratins in a well-de®ned pattern (Fuchs,
1990). Orchidectomy of mice results in a decreased mitotic activity
in epidermis, which can be counteracted by estrogen treatment
(Bullough and Van Oordt, 1950; Allen, 1956). Estrogen treatment
of female mice also results in an increased epidermal thickness
associated with increased mitotic activity (Bullough, 1947).
Furthermore, castration of humans results in a decreased epidermal
thickness, which can be reversed by estrogen treatment (Punnonen,
1972).
There is still little conclusive information prior to this study as to
which of the two ER is functionally important in skin and hair.
The aim of this study was to investigate the relative functional
importance of ERa and ERb in the regulation of the hair follicle
cycling and epidermal thickness in male mice. We used transgenic
male mice lacking one or both of the known ER, ERa/b. The
mice were orchidectomized and treated with either 17b-estradiol
or vehicle.
MATERIALS AND METHODS
Animals Male double heterozygous (ERa+/±b+/±) mice were mated
with female double heterozygous (ERa+/±b+/±) mice, resulting in wild-
type (WT), ERa ±/±ERb+/+ (ERKO), ERa+/+ERb±/± (BERKO), and
ERa ±/±ERb±/± (DERKO) offspring with a mixed C57BL/6 J/129
background (Lubahn et al, 1993; Krege et al, 1998). Genotyping of tail
DNA was performed at 3 week of age as previously described (Vidal et al
2000). Animals had free access to fresh water and food pellets (B & K
Universal AB, Sollentuna, Sweden) consisting of cereal products (76.9%
barley, wheat feed, and maize germ), vegetable proteins (14.0% hipro
soya), and vegetable oil (0.8% soya oil). All mice were orchidectomized
at 7 month of age. The mice were left to recover for 10 d after
orchidectomy. After recovery, mice were injected s.c. with 0.7 mg 17b-
estradiol benzoate per mouse per day (Sigma, St Louis, MO) for 5 d per
week during 3 week. Control mice received injections of vehicle oil
(olive oil, Apoteksbolaget, GoÈteborg, Sweden). Treatment with 0.7 mg
17b-estradiol benzoate per mouse per day resulted in 17b-estradiol levels
of approximately 60 pg per ml (220 pmol per l).
Morphologic analyzes and histochemistry Skin biopsies from the
dorsal surface were ®xed overnight in 10% phosphate-buffered formalin
and stored in 70% ethanol before embedding in paraf®n and cutting into
5 mm sections. Sections for morphologic analyzes were stained with
hematoxylin and eosin or by using the sacpic method (Nixon, 1993).
Measurements were done using digital images. Eight measurements in at
least four randomly selected sections from each animal were used for
epidermal and dermal thickness analyzes. The epidermal thickness was
de®ned as the distance between the stratum corneum and the basement
membrane, whereas the dermal thickness was de®ned as the distance
between the epidermis and panniculus carnosus (n = 4±6). For
measurements of hair thickness, hairs were plucked from the dorsal
surface and placed on glass slides. Hair thickness was determined at the
widest point of the hair shaft in digital images of 25 hairs of each animal
(n = 4).
Immunohistochemistry For immunohistochemistry studies, endo-
genous peroxidase activity was removed by treatment with 0.3% H2O2
for 20 min. To expose the antigen, sections for Ki-67 staining were
microwaved in 10 mM sodium citrate (pH 6.0), twice for 5 min Sections
were blocked in 10% normal goat serum (Dako A/S, Denmark)/1%
bovine serum albumin (Sigma)/phosphate-buffered saline. Primary
antibodies were diluted in 1% normal goat serum/0.1% bovine serum
albumin/phosphate-buffered saline at the following dilutions: rabbit
polyclonal antimouse keratin (MK)-1 (1 : 1000); -MK-5 (1 : 500); -MK-
6 (1 : 1000); -MK-10 (1 : 100); -MK-14 (1 : 5000); -®laggrin (1 : 1000)
(Babco, Richmond, CA); and -Ki-67 (1 : 2000) (Novocastra, Newcastle
upon Tyne, U.K). Incubation was for 1 h at room temperature. Sections
were then incubated with biotin-conjugated goat antirabbit IgG (Santa
Cruz Biotechnology, Santa Cruz, CA), diluted 1 : 200 followed by
incubation with Vectastain Elite ABC kit (Vector Laboratories, Inc.,
Burlingame, CA). Visualization of the immunostaining was achieved
using diaminobenzidine as the substrate. Sections were counterstained
with hematoxylin. For the determination of Ki-67-positive cells, at least
400 cells of the basal cell layer in epidermis were counted in each animal
(n = 4).
Terminal deoxynucleotidyl transferase-mediated deoxyuridine
triphosphate nick end-labeling (TUNEL) assay The apoptotic
keratinocytes were detected using the ApopTag in situ Apoptosis
Detection Kit according to the manufacturer's protocol (Gavrieli et al,
1992) (TUNEL assay; Intergen, Purchase, NY). Visualization was
achieved using diaminobenzidine as the substrate and sections were then
subjected to nuclear counterstaining with methyl green. Five sections per
mouse were analyzed for the TUNEL+ calculations (n = 4).
RESULTS
Activation of ERa, but not ERb, inhibits orchidectomy
induced telogen±anagen transition To study the role of
estrogen and the relative importance of ERa and ERb in hair cycle
regulation, animals were subjected to orchidectomy, followed by
treatment with 17b-estradiol or vehicle. As expected, orchid-
ectomy induced a synchronized anagen phase of the hair follicles,
characterized by the presence of hair follicles in anagen III±VI or
catagen stages located in the subcutis in all four genotypes (Fig 1)
(MuÈller-RoÈver et al 2001). Treatment with 17b-estradiol for
3 week inhibited this orchidectomy-induced anagen initiation in
WT and BERKO, but not in ERKO and DERKO mice (Fig 1).
The hair follicles in 17b-estradiol-treated WT and BERKO mice
were exclusively in telogen or anagen I±II and found in the dermis
but not in the subcutis (MuÈller-RoÈver et al 2001). The hair follicles
in the estrogen-treated ERKO and DERKO mice were all in
anagen III±VI or catagen stages (MuÈller-RoÈver et al 2001). The
thickness of the hair was neither in¯uenced by genotype nor
treatment with estrogen (Table 1). These data demonstrate that
estrogen-induced activation of ERa, but not ERb, inhibits
orchidectomy-induced telogen±anagen transition in mice. When
studying the hair follicle cycle in intact mice, there was no
signi®cant difference between the occurence of telogen/anagen I±
II and anagen III±VI/catagen stages between the different
genotypes (WT 91 6 6%, ERKO 79 6 9%, BERKO 87 6
13%, DERKO 90 6 5% of hair follicles in telogen/anagen I±II,
n = 5).
ERa, but not ERb, is involved in the effect of estrogen on
the thickness of epidermis in orchidectomized mice In this
study, we observed that following orchidectomy, epidermis was
thin in all four genotypes (Figs 2, 3A). Treatment with 17b-
estradiol increased the thickness of epidermis in WT and BERKO,
but not in ERKO and DERKO, demonstrating the importance of
ERa in the regulation of epidermal thickness. ANOVA on the
comparison of all estrogen-treated groups demonstrated a minor
but signi®cant difference between estrogen-treated WT mice and
estrogen-treated BERKO mice. This ®nding might indicate that
ERb actually exerts a minor effect in the regulation of epidermal
thickness; however, ERb did not by itself mediate any effect of
estrogen as demonstrated by the lack of estrogen effect in
orchidectomized ERKO mice. The dermal thickness was not
changed by 17b-estradiol in any genotypes (Fig 3B). Alterations in
the thickness of epidermis may depend on changes in the
proliferation, apoptosis, and/or changes in the differentiation of
the epidermal cells.
To evaluate if the estrogen-induced increased thickness of
epidermis in WT and BERKO mice, was caused by an altered
proliferative rate of the basal cells in the epidermis, immunostaining
for Ki-67 was performed. Ki-67 is a nuclear protein expressed by
cells during the G1, G2, and M phase of the cell cycle, and is used as
a marker for cell proliferation (Sasaki et al, 1987; Schluter et al,
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1993). The number of Ki-67-positive cells in the basal cell layer of
the epidermis in the vehicle-treated ERKO, BERKO, and
DERKO mice did not differ from the vehicle-treated WT mice
(Fig 4). 17b-estradiol treatment increased the number of Ki-67-
positive cells in the basal cell layer of the epidermis in WT and
BERKO mice, but not in ERKO and DERKO mice, indicating
that ERa mediates the stimulatory effect of estrogen on the
proliferation of basal cells in epidermis. The apoptotic rate in
epidermis was determined by using the TUNEL technique. This
assay revealed, as expected, a high frequency of TUNEL-positive
cells in testis, which was included as our positive control (Billig et al,
1995). The number of TUNEL-positive cells was very low in the
epidermis of these 8-month-old male mice. Therefore, the
quanti®cation of TUNEL-positive cells was dif®cult to perform.
No major difference in keratinocyte TUNEL positivity, however,
was apparent between the different genotypes (data not shown).
Altered thickness of epidermis can also depend on changes in the
differentiation of the epidermal cells. To determine the importance
of ERa and ERb for the epidermal differentiation, the expression
patterns of several keratin markers were investigated. The basal cell
layer in the epidermis normally expresses keratin K5 and K14
(Fuchs, 1990). WT and BERKO mice treated with 17b-estradiol
showed expression of K14 not only in the basal cell layer but also in
the suprabasal layer (Fig 5, and data not shown). The expression
pattern of K5 in the basal cell layer in WT and BERKO treated
with 17b-estradiol was associated with an increased thickness of
epidermis (Fig 5, and data not shown). The expression of K5 and
K14 in 17b-estradiol-treated ERKO and DERKO mice were
restricted to the basal cell layer of epidermis (Fig 5, and data not
shown).
K1 and K10 are normally expressed later during the differen-
tiation of the keratinocytes by cells in the suprabasal layer (Fuchs,
1990). The expression pattern of K1 and K10 was similar in the
four genotypes treated with 17b-estradiol (Fig 5, and data not
shown).
Filaggrin is typically expressed in the granular layer and treatment
with 17b-estradiol resulted in a high expression of ®laggrin in WT
and BERKO but not in ERKO and DERKO mice (Fig 5, and
data not shown). K6 is occasionally expressed in the suprabasal layer
of epidermis and is regarded as a marker for hyperproliferation of
the keratinocytes (Mansbridge and Knapp, 1987; Weiss et al, 1984;
Fuchs, 1990). WT and BERKO mice treated with 17b-estradiol
had a patchy expression of K6 in the suprabasal layer of epidermis,
whereas no expression of K6 was found in epidermis of ERKO or
DERKO mice (Fig 5, and data not shown).
DISCUSSION
Estrogen is of importance for the regulation of hair growth and
epidermal thickness (Hooker, 1943; Bullough, 1947; Houssay,
Table 1. Effects of estrogen on hair thickness
Genotype Treatment Hair thickness (mm)
WT Vehicle
17b-estradiol
43.7 6 3.9
46.5 6 1.1
ERKO Vehicle
17b-estradiol
41.8 6 1.6
46.8 6 1.8
BERKO Vehicle
17b-estradiol
43.1 6 2.3
48.6 6 2.1
DERKO Vehicle
17b-estradiol
42.7 6 1.8
44.8 6 1.0
Seven-month-old mice were orchidectomized and treated with 0.7 mg per mice
per day of 17b-estradiol or vehicle for 3 week. Twenty-®ve hairs from each
mouse were analyzed and values are given as mean 6 SEM (n = 4). Student's t test
were used as the statistical test.
Figure 1. 17b-estradiol inhibits the telogen±anagen transition in WT and BERKO but not in ERKO or DERKO mice. Sacpic staining of
dorsal skin (original magni®cation 3100). Seven month old mice were orchidectomized and treated with 0.7 mg per mice per day of 17b-estradiol (E)
or vehicle (V) for 3 week (n = 4±6). Bar: 250 mm.
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1953; Oh and Smart, 1996). The effects of estrogen have
predominantly been studied in females; however, recent studies
demonstrate that estrogen also is critical for males (Ogawa et al
2000; Ohlsson et al 2000; Vidal et al 2000; Lindberg et al 2002).
Some effects of androgens, including regulation of skeletal growth,
trabecular bone mineral density, fat mass, and sexual behavior,
earlier regarded as mediated via the androgen receptor, have
recently been re-evaluated and are now, at least partly, considered
to be mediated via aromatization of androgens into estrogen. Effects
of estrogen and the relative functional importance of ERa and
ERb in the regulation of hair follicle cycling and epidermal
thickness were investigated in male mice in this study.
Hair Earlier studies have shown that estrogen is important for the
regulation of hair growth (Smart et al, 1999; Chanda et al 2000) and
it is speculated that this effect of estrogen is mediated via ERa as
this receptor is highly expressed locally in the skin (Oh and Smart,
1996; Chanda et al 2000). We clearly demonstrate that ERa but
not ERb is involved in the effect of estrogen on the regulation of
telogen±anagen transition in orchidectomized mice. Thus, ERa-
speci®c agonists and antagonists might be useful for the regulation
of hair growth in males. This study does not exclude the possibility
that androgen also regulates hair growth directly via the androgen
receptor. A possible direct effect via the androgen receptor could be
investigated by treating orchidectomized mice with the non-
aromatizable androgen dihydrotestosterone. The hair thickness was
not altered by ER inactivation in this study.
Skin Castration causes a thinning of the epidermal thickness and
this can be reversed by estrogen treatment (Allen, 1956; Punnonen,
1972). In this study, we demonstrated that the positive effect of
estrogen on epidermal thickness is mediated via ERa and not ERb
in orchidectomized mice. We propose that an ERa-speci®c agonist
might be useful to increase epidermal thickness in conditions
associated with epidermal atrophy, whereas an ERa-speci®c
antagonist might be of value in the treatment of diseases
associated with epidermal hypertrophy. Alterations in the
epidermal thickness can depend on changes in the proliferation
Figure 2. 17b-estradiol increases epidermal thickness in orchidectomized WT and BERKO but not in ERKO or DERKO mice.
Hematoxylin and eosin staining of dorsal skin (original magni®cation 3 400). Seven month old mice were orchidectomized and treated with 0.7 mg
per mice per day of 17b-estradiol (E) or vehicle (V) for 3 week. (n = 4±6). Bar: 25 mm.
Figure 3. Effects of 17b-estradiol on thickness of (A) epidermis
and (B) dermis in WT, ERKO, BERKO, and DERKO mice. Seven
month old mice were orchidectomized and treated with 0.7 mg per mice
per day of 17b-estradiol (E) or vehicle (V) for 3 week. (n = 4±6). Values
are given as mean 6 SEM. **p < 0.01, estrogen vs. vehicle, Student's t
test; +p < 0.05 ANOVA followed by Student±Neuman±Keuls multiple
range test, on the comparison of all estrogen-treated groups (WT
estrogen, ERKO estrogen, BERKO estrogen, and DERKO estrogen).
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rate or in the terminal differentiation of the keratinocytes. We
found that the number of Ki-67-positive cells in the basal cell layer
of the epidermis is increased by estrogen in orchidectomized WT
and BERKO mice. Therefore, the increase of the epidermal
thickness by estrogen in WT and BERKO mice can, at least to
some extent, be explained by an increase in mitotic activity of the
keratinocytes in the basal cell layer. 17b-estradiol treatment did not
have any effect on the epidermal thickness in ERKO and DERKO,
clearly demonstrating that this effect of estrogen is mediated
through the ERa and not ERb. An ERa-mediated increased
proliferative rate in the epidermis is supported by the fact that
estrogen-treated WT and BERKO but nor ERKO and DERKO
mice demonstrated a patchy expression of K6. This keratin is
normally not expressed in epidermis; however, when it is expressed
in the epidermis, it is associated with a hyperproliferative condition
(Fuchs, 1990).
Possible effects of estrogen on epidermal differentiation were
investigated by the expression pattern of several keratin markers. K5
and K14 immunoreactivity were restricted to the basal cell layer of
the epidermis in ERKO and DERKO mice treated with 17b-
estradiol, whereas in WT and BERKO, K5 and K14 were also
expressed in the suprabasal cell layer. This ®nding demonstrates that
17b-estradiol via ERa alters the distribution of these two keratins.
The expression of the keratins was only investigated on the protein
level, and it can therefore not be excluded that the mRNA
encoding K5 and K14 nevertheless only is synthesized by the
keratinocytes in the basal cell layer of the epidermis. Furthermore,
we cannot say if the expression of these two keratins is increased or
if it is the stability of the proteins that is altered by 17b-estradiol
treatment in these mice. Increased stability of K5 and K14 has
previously been described in K10 null mice (Reichelt et al 2001).
The expression of ®laggrin was restricted to the outermost cell layer
of the epidermis in all genotypes treated with 17b-estradiol;
however, ®laggrin was more intensely expressed in WT and
BERKO than in ERKO and DERKO mice treated with 17b-
estradiol. This ®nding might indicate that not only the proliferation
of the keratinocytes but also the terminal differentiation is altered
by the 17b-estradiol treatment.
Keratinocyte growth factor and epidermal growth factor are
involved in the regulation of proliferation and differentiation of
keratinocytes and it is previously demonstrated that these two
factors are up-regulated by estrogen (Werner, 1998; Gibbs et al
2000). Furthermore, there is a coupling between the epidermal
growth factor and ER signaling pathways (Curtis et al, 1996; Stoica
et al 2000). Therefore, one may speculate that keratinocyte growth
factor and epidermal growth factor might be involved in the effect
of estrogen on epidermal thickness.
In conclusion, estrogen is of importance for the regulation of hair
follicle cycling and epidermal thickness in male mice. The effect on
hair follicle cycling is caused by an ERa-mediated inhibition of
telogen±anagen transition and the effect of estrogen to increase
epidermal thickness is associated with an ERa-mediated increase in
the proliferative rate of the keratinocytes in the basal cell layer of
epidermis.
Figure 4. Effects of 17b-estradiol on Ki-67-positive cells. Cells
positive by immunohistochemical staining for the Ki-67 proliferation
marker in the basal cell layer of epidermis. (n = 4). Values are given as
mean 6 SEM and expressed as percentage Ki-67-positive cells. *p
< 0.05, **p < 0.01, estrogen vs. vehicle, Student's t test.
Figure 5. Effects of 17b-estradiol on epidermal differentiation in
WT and ERKO mice. Immunohistochemistry showing the expression
of K1, K5, K6, K10, K14 and ®laggrin. Seven month old mice were
orchidectomized and treated with 0.7 mg 17b-estradiol per mice per day
for 3 week (n = 4±6). Counterstaining with hematoxylin. Bar: 25 mm.
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